What is the typical dosing of diltiazem (calcium channel blocker) for hypertension or angina?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diltiazem Dosing for Hypertension and Angina

For hypertension and angina, diltiazem is typically dosed at 120-360 mg daily, with hypertension often requiring higher doses (up to 360 mg daily) compared to angina (typically 240 mg daily). 1, 2

Dosing Guidelines

Oral Dosing

  • Initial dose: 120 mg daily in divided doses or as a single dose with long-acting formulations 1
  • Maximum maintenance dose: 360 mg daily in divided doses or as a single dose with long-acting formulations 1
  • Hypertension: Often requires higher doses (240-360 mg daily) for optimal blood pressure control 2, 3
  • Angina: Usually effective at 180-240 mg daily, though some patients may require up to 360 mg daily 4

Extended-Release Formulations

  • Once-daily formulations (CD/XR): Provide 24-hour blood pressure control with improved compliance 5, 3
  • Twice-daily formulations (SR): Equally effective but require twice-daily administration 5
  • Dose titration: Start with lower doses (120-180 mg daily) and titrate upward based on clinical response 3

Contraindications and Precautions

Avoid in patients with:

  • AV block greater than first degree or SA node dysfunction (without pacemaker) 1, 6
  • Hypotension 1, 6
  • Decompensated systolic heart failure or severe LV dysfunction 1
  • Wolff-Parkinson-White (WPW) syndrome with atrial fibrillation/flutter 1, 6

Drug Interactions:

  • Diltiazem is a substrate of CYP3A4 (major) and a moderate CYP3A4 inhibitor 1
  • Use caution with: apixaban, itraconazole, bosutinib, ceritinib, cilostazol, cyclosporine, everolimus, ibrutinib, idelalisib, ivabradine, lomitapide, olaparib, ranolazine, rifampin, simeprevir 1

Potential Adverse Effects

  • Hypotension (most common) 1, 6
  • Worsening heart failure in patients with pre-existing ventricular dysfunction 1, 6
  • Bradycardia 1, 6
  • Abnormal liver function tests (rare) 1
  • Acute hepatic injury (rare) 1
  • Peripheral edema (especially at higher doses) 4

Clinical Pearls

  • Dose-response relationship is linear through the 480-540 mg/day range for hypertension 2
  • 90-120 mg/day range is considered the "no-effect dose" for hypertension 2
  • Diltiazem is often underdosed for hypertension; when properly dosed, it can be highly effective 2, 3
  • For angina, diltiazem works through reduction in myocardial oxygen demand and increased supply via coronary artery dilation 4
  • When using extended-release formulations, plasma concentrations ≥40 ng/mL are considered within therapeutic range 3
  • Caution regarding orthostatic hypotension when combining high-dose diltiazem with nitrate therapy 4

Monitoring

  • Blood pressure and heart rate 1
  • Signs and symptoms of heart failure in at-risk patients 1
  • Liver function tests if clinically indicated 1
  • ECG monitoring in patients with conduction system disease 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Anomalies in the dosing of diltiazem.

Clinical cardiology, 2000

Research

Effectiveness of diltiazem for chronic stable angina pectoris.

Acta pharmacologica et toxicologica, 1985

Guideline

Diltiazem Dosing for Paroxysmal Supraventricular Tachycardia (PSVT)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.